Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone

BACKGROUND: Surgical resection with curative intent for giant cell tumor of bone (GCTB) may be associated with severe morbidity. This interim analysis evaluated reduction in surgical invasiveness after denosumab treatment in patients with resectable GCTB. METHODS: Patients with primary or recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Piotr, Ferrari, Stefano, Grimer, Robert J., Stalley, Paul D., Dijkstra, Sander P. D., Pienkowski, Andrzej, Vaz, Gualter, Wunder, Jay S., Seeger, Leanne L., Feng, Amy, Roberts, Zachary J., Bach, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Bone and Soft Tissue Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531146/
https://www.ncbi.nlm.nih.gov/pubmed/26033180
http://dx.doi.org/10.1245/s10434-015-4634-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531146/
https://www.ncbi.nlm.nih.gov/pubmed/26033180
http://dx.doi.org/10.1245/s10434-015-4634-9

Ejemplares similares